Dr Alexeev is a Senior Research Fellow specializing in Health Economics at the NHMRC Clinical Trials Centre, Faculty of Medicine and Health, The University of Sydney. With a Master's degree in Finance from Paris Dauphine University, a Master's degree in Economics from York University, and a PhD in Economics from the University of Technology Sydney (obtained in 2020), he brings a wealth of knowledge and expertise to the health field.

As an experienced economist, econometrician, and trial methodologist, Dr Alexeev is well-versed in experimental and quasi-experimental research methods. Robust evaluation of cluster randomized trials is his current area of particular interest. He is the lead methodologist for the prestigious multi-site cluster randomized controlled trial "Transforming Nursing Assessment in Acute Hospitals (ENCORE)." A series of papers based on ENCORE (including one methodology paper) is soon to be published.

Demonstrating his commitment to advancing healthcare research, Dr Alexeev is currently developing an MRFF Partners Grant titled "Health Consequences of Incarceration in Australia (A-SOCIAL)" in collaboration with Corrective Services NSW.

His expertise and leadership as Chief Investigator have also been recognized through his submission of the grant proposal titled "SiMPLicity - Self-managing Multimorbidity for People with a Lived Experience of Schizophrenia: A Co-Designed Digital Health Ecosystem" to the 2021 MRFF Early to Mid-Career Researchers program. Additionally, in 2020, he submitted a grant proposal titled "The Impact of Imprisonment on Recidivism, Employment, Earnings, and Health" to the ARC Linkage projects.

He has an impressive publication record, with seven manuscripts published in reputable economics and health journals, including three in 2022 and one in 2023. As the lead author on five of these publications, his work has garnered significant attention, receiving 27 citations and resulting in an h-index of 4, according to Google Scholar. His rigorous research has consistently appeared in highly regarded journals, underscoring his dedication to producing high-quality scholarship.

Recognizing the importance of disseminating research findings to a wider audience, Dr Alexeev has also written six media articles based on his published research. Notably, his paper titled "Harm reduction or amplification? The adverse impact of a supervised injection room on housing prices" has received extensive national media coverage in Australia, reflecting the societal relevance and impact of his work.

Dr Alexeev's expertise is widely recognized within his field, and he actively contributes to the academic community through his role as a peer reviewer for top-tier field journals. Furthermore, he consistently engages in conferences, research seminars, and collaborative team meetings, furthering the exchange of knowledge and fostering innovative research practices.

Overall, Dr Alexeev's impressive credentials, extensive publication record, grant submissions, media coverage, and active involvement in the academic community underscore his status as a highly accomplished researcher and valuable asset to the field of Health Economics.